Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
In investing, certain stocks catch the discerning eye of big players, drawing in substantial investments.
As the holiday season approaches, the tech stock market shines brightly, with innovative sparks illuminating various sectors.
Intensity Therapeutics (NASDAQ:INTS) stock is rising higher on Friday after the clinical-stage biotechnology company revealed positive results from a clinical trial. These results come from...
Recent Healthcare Stocks Articles
Intensity Therapeutics stock is taking off on Thursday as investors in INTS react to positive results from a Phase 2 clinical trial.
Avid Bioservices stock is falling hard on Friday as investors in CDMO react to a lackluster earnings report and a guidance cut.
Exicure stock is rising higher on Friday with heavy trading of XCUR shares despite a lack of news from the biotechnology company.
As cannabis becomes legalized in more regions of the world, it's high time that you check out the best cannbis stocks to buy in December.
Global healthcare spending reached a record $9 trillion in 2020. Catch the ongoing benefits with these three long-term healthcare stock picks.
Cerevel Therapeutics stock is climbing higher as CERE investors react to an $8.7 billion acquisition deal with AbbVie.
ZyVersa Therapeutics stock is falling hard on Thursday after the company priced a public offering for shares of ZVSA this morning.
Hempacco stock is rising higher on Thursday as HPCO investors react to news of a new distribution agreement in India and Thailand.
These three gene therapy stocks should get huge boosts over the long term from the use of gene editing techniques to treat diseases.
With the equities sector falling flat while the cryptocurrency arena skyrockets, the difficulties associated with planning next moves help drive the bullish case for dividend-paying...
With this healing economy, you must buy these telehealth stocks now to increase your portfolio value in 2024 during the telehealth revolution.
These high-dividend stocks are among the biggest beneficiaries of current mega trends, and investors can leverage them for big gains.
With an oversight board recommending Sera Prognostics halt its clinical study for efficacy, SERA stock soared on the positive implications.
Pharvaris stock is rising higher on Wednesday following news of an underwritten offering for PHVS shares and pre-funded warrants.
ZyVersa Therapeutics stock is rising with heavy trading of ZVSA shares after a paper was published in a peer-reviewed journal.
ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA.
These AI stocks will transform your portfolio into a gem in 2024, as they're sparkling jewels presenting unparalleled growth.
Investors in retail pharmacy chain CVS are cheering today, as CVS stock has surged roughly 4% this afternoon on positive earnings.